The life-sparing potential of mammographic screening

Cancer

Volumn 91, Issue 9, 2001, Pages 1699-1703

  Cady, Blake ^a   Michaelson, James S ^b  

^a BROWN UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; MAMMOGRAPHY; NOTE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; SURVIVAL RATE; SWEDEN;

EID: 0035340697     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010501)91:9<1699::AID-CNCR1186>3.0.CO;2-W     Document Type: Note

References (30)

1. Beyond randomized controlled trials: Organized mammographic screening substantially reduces breast cancer mortality
2. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up
3. Is screening for breast cancer with mammography justifiable?
4. Principles of successful cancer screening
5. The evolution of paradigms for the management of breast cancer: A personal perspective
6. Karnofsky Memorial Lecture. Natural history of small breast cancers
7. The rationale for early diagnosis of cancer - The example of breast cancer
8. Benefit of screening mammography in women aged 40-49: A new meta-analysis of randomized controlled trials
9. Breast cancer: Computer simulation method for estimating optimal intervals for screening
10. Canadian National Breast Screening Study-2: 13-Year results of a randomized trial in women aged 50-59 years
11. Screening mammography re-evaluated
12. The breast carcinoma screening interval is important
13. The natural history of breast carcinoma: What have we learned from screening?
14. Interval cancers in the Dutch breast cancer screening programme
15. Ten-year risk of false positive screening mammograms and clinical breast examinations
16. New era in breast cancer. Impact of screening on disease presentation
17. Internation Union Against Cancer. Classification of isolated tumor cells and micrometastasis
18. Minimal solid tumor involvement of regional and distant sites: When is a metastasis not a metastasis?
19. Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,b NO MO)
20. A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: A0 prospective study
21. Incidence of and treatment for ductal carcinoma in situ of the breast
22. How to prevent invasive breast cancer: Detect and excise duct carcinoma in situ
23. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast
24. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy
25. Intraductal carcinoma: Long-term follow-up after treatment by biopsy alone
26. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years
27. The American Cancer Society challenge goals: How far can cancer rates decline in the U.S. by the year 2015?
28. Comparison of mammography and Pap test use from the 1987 and 1992 National Health Interview Surveys: Are we closing the gaps?